Accreditation Information

Accreditation

Creative Educational Concepts is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing (ANCC)

This activity is designated for 1.5 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Nursing (AANP) 

This activity is approved for 1.5 contact hours of continuing education (which includes 1.0 hour pharmacology) by the American Association of Nurse Practitioners.

This activity was planned in accordance with AANP Accreditation Standards and Policies

Objectives

  1. Explain risk factors for development of tardive dyskinesia in the psychiatric practice setting.
  2. Using video cases, evaluate for drug-induced abnormal movements in patients at risk for developing tardive dyskinesia.
  3. Explore novel treatment options for tardive dyskinesia, considering efficacy, safety, and practical issues for the advanced practice psychiatric nurse.
  4. Demonstrate best practices the advanced practice nurse may employ in the frontline assessment of tardive dyskinesia and implementation of treatment protocols to improve patient outcomes.

Target Audience

Psychiatric-mental health nurses attending the 15th Annual American Psychiatric Nurses Association (APNA) Clinical Psychopharmacology Institute (CPI) who care for psychiatric patients at risk for tardive dyskinesia.

Faculty Disclosure

Planner and Faculty Disclosures

In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Planner:

Joan B. Fowler, PharmD, BCPP – has no relevant financial relationships to disclose in relation to the content of this activity.

Author/Presenters:

Jason P. Caplan, MD, FAPM, FAPA - has disclosed that he is a consultant for Avanir and Otsuka and a member of the speakers' bureaus for Acadia, Avanir, and Neurocrine Biosciences Inc. 

Steven C. Stoner, PharmD, BCPP – has no relevant financial relationships to disclose in relation to the content of this activity.

Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN - has no relevant financial relationships to disclose in relation to the content of this activity.

Dawn M. Vanderhoef, PhD, DNP, PMHNP-BC, FAANP – has disclosed that she is a member of the speakers' bureau for Neurocrine Biosciences, Inc. 

Peer Reviewer:

Leigh Anne Nelson, PharmD, BCPP - has no relevant financial relationships to disclose in relation to the content of this activity.

Laura J. Thiem, DNP, RN, FNP-BC, Adult PMHCNS-BC, Adult PMHNP-BC, CNE - has no relevant financial relationships to disclose in relation to the content of this activity.